Pathologies of the brain, of which brain cancer, Alzheimer's disease, Parkinson's disease,
stroke, and multiple sclerosis, are some of the most prevalent, and that presently are poorly …

The development of cancer diagnostic imaging and treatment is a major concern worldwide.
By integrating imaging and therapy into one theranostic nanoplatform for simultaneously …

Treatment of certain central nervous system disorders, including different types of cerebral
malignancies, is limited by traditional oral or systemic administrations of therapeutic drugs …

Drug delivery to the brain has been one of the toughest challenges researchers have faced
to develop effective treatments for brain diseases. Owing to the blood–brain barrier (BBB) …

The treatment of Parkinson's disease (PD) is hampered by the blood-brain barrier (BBB). As
such, there is an urgent need for the development of a novel nanoplatform capable of …

Globally, stroke is a leading cause of death and long-term disability. Over the past decades,
several efforts have attempted to discover new drugs or repurpose existing therapeutics to …

Ischemic stroke is a vascular central nervous system (CNS) disease that leads a disability
and death. Thrombolysis and neuroprotection are the primary treatment strategies of …

Dendrimers are polymers with well‐defined 3D branched structures that are vastly utilized in
various neurotheranostics and biomedical applications, particularly as nanocarrier vectors …

From the global perspective, stroke refers to a highly common cause of disability and death.
Ischemic stroke (IS), attributed to blood vessel blockage, preventing the flow of blood to …

Ischemic stroke is a complex, high-mortality disease with multifactorial etiology and
pathogenesis. Currently, drug therapy is mainly used treat ischemic stroke in clinic, but there …